APA (7th ed.) Citation

T, S., J, S., & F, L. (2024). Treatment of Secondary Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-cell Lymphoma Using Loncastuximab Tesirine As Lymphoma-Directed Therapy. Cureus, 16(9), e70450. https://doi.org/10.7759/cureus.70450

Chicago Style (17th ed.) Citation

T, Schieber, Snyder J, and Lutfi F. "Treatment of Secondary Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-cell Lymphoma Using Loncastuximab Tesirine As Lymphoma-Directed Therapy." Cureus 16, no. 9 (2024): e70450. https://doi.org/10.7759/cureus.70450.

MLA (9th ed.) Citation

T, Schieber, et al. "Treatment of Secondary Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-cell Lymphoma Using Loncastuximab Tesirine As Lymphoma-Directed Therapy." Cureus, vol. 16, no. 9, 2024, p. e70450, https://doi.org/10.7759/cureus.70450.